Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

Clinical trial NCT00454363 · COMPLETED

Trial details

NCT number: NCT00454363
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrin-Producing Neuroendocrine Tumor Lung Carcinoid Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Multiple Endocrine Neoplasia Type 1 Pancreatic Glucagonoma Pancreatic Insulinoma Pancreatic Polypeptide Tumor Recurrent Digestive System Neuroendocrine Tumor G1 Recurrent Pancreatic Neuroendocrine Carcinoma Regional Digestive System Neuroendocrine Tumor G1 Somatostatin-Producing Neuroendocrine Tumor

Start date: 2007-03-01
Primary completion: 2014-03-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.